Hemopressin as a breakthrough for the cannabinoid field.
- DOI
- 10.1016/j.neuropharm.2020.108406
- Published
- 2020-11-16
- Container
- Neuropharmacology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neuropharm.2020.108406,
title = {Hemopressin as a breakthrough for the cannabinoid field.},
author = {Heimann AS and Dale CS and Guimarães FS and Reis RAM and Navon A and Shmuelov MA and Rioli V and Gomes I and Devi LL and Ferro ES.},
year = {2021},
journal = {Neuropharmacology},
doi = {10.1016/j.neuropharm.2020.108406},
url = {https://doi.org/10.1016/j.neuropharm.2020.108406}
}RIS
TY - JOUR TI - Hemopressin as a breakthrough for the cannabinoid field. AU - Heimann AS AU - Dale CS AU - Guimarães FS AU - Reis RAM AU - Navon A AU - Shmuelov MA AU - Rioli V AU - Gomes I AU - Devi LL AU - Ferro ES. PY - 2021 JO - Neuropharmacology DO - 10.1016/j.neuropharm.2020.108406 UR - https://doi.org/10.1016/j.neuropharm.2020.108406 ER -
APA
AS, H., CS, D., FS, G., RAM, R., A, N., MA, S., V, R., I, G., LL, D., & ES., F. (2021). Hemopressin as a breakthrough for the cannabinoid field.. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2020.108406
Source records
- europe-pmc · retrieved 2026-09-26T17:34:50.689Z